BioengineeringbioRxiv
Safety and biodistribution of NanoligomersTM targeting SARS-CoV-2 genome for treatment of COVID-19
C. R. McCollum, C. M. Courtney, N. J. O'Connor…·A. Chatterjee
This paper evaluates the safety and biodistribution of a novel Nanoligomer targeting SARS-CoV-2 in mice, showing it is safe, nontoxic, and effectively distributed throughout the body.
DOI 10.1021/acsbiomaterials.2c00669